Concepts (134)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Blood Platelets | 7 | 2016 | 2508 | 0.410 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 2009 | 472 | 0.290 |
Why?
|
Cell-Derived Microparticles | 3 | 2012 | 168 | 0.280 |
Why?
|
Infarction, Middle Cerebral Artery | 3 | 2013 | 475 | 0.200 |
Why?
|
Cytotoxicity, Immunologic | 2 | 2023 | 1369 | 0.190 |
Why?
|
Gene Expression Regulation, Neoplastic | 3 | 2021 | 8428 | 0.190 |
Why?
|
Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2021 | 290 | 0.170 |
Why?
|
Killer Cells, Natural | 3 | 2023 | 2133 | 0.170 |
Why?
|
Multiple Myeloma | 3 | 2023 | 5181 | 0.160 |
Why?
|
Mucin-1 | 1 | 2023 | 543 | 0.160 |
Why?
|
Exosomes | 1 | 2023 | 417 | 0.160 |
Why?
|
Neovascularization, Physiologic | 5 | 2016 | 1351 | 0.160 |
Why?
|
Neovascularization, Pathologic | 3 | 2016 | 2635 | 0.120 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2023 | 1378 | 0.120 |
Why?
|
Drug Resistance, Neoplasm | 3 | 2023 | 5172 | 0.110 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2023 | 1596 | 0.110 |
Why?
|
Hematologic Neoplasms | 1 | 2023 | 1832 | 0.100 |
Why?
|
Neurogenesis | 3 | 2013 | 838 | 0.100 |
Why?
|
Tumor Microenvironment | 3 | 2023 | 3586 | 0.100 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2021 | 1861 | 0.100 |
Why?
|
Neural Stem Cells | 3 | 2013 | 851 | 0.100 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2021 | 2916 | 0.090 |
Why?
|
Prostatic Neoplasms | 2 | 2012 | 11124 | 0.090 |
Why?
|
Protein Synthesis Inhibitors | 1 | 2009 | 192 | 0.080 |
Why?
|
Antineoplastic Agents | 2 | 2023 | 13695 | 0.080 |
Why?
|
Cycloheximide | 1 | 2009 | 347 | 0.080 |
Why?
|
Dactinomycin | 1 | 2009 | 318 | 0.080 |
Why?
|
Sulfinic Acids | 1 | 2008 | 13 | 0.080 |
Why?
|
Neoplasms | 3 | 2023 | 21683 | 0.080 |
Why?
|
NF-kappa B | 1 | 2016 | 2499 | 0.080 |
Why?
|
Gelatin | 1 | 2009 | 225 | 0.070 |
Why?
|
Platelet Activation | 2 | 2012 | 673 | 0.070 |
Why?
|
Cell Line, Tumor | 4 | 2023 | 16689 | 0.070 |
Why?
|
Endothelial Cells | 3 | 2008 | 3479 | 0.070 |
Why?
|
Histocompatibility Antigens Class I | 2 | 2023 | 1366 | 0.070 |
Why?
|
Wound Healing | 1 | 2016 | 2785 | 0.070 |
Why?
|
Fibroblast Growth Factor 2 | 3 | 2016 | 599 | 0.060 |
Why?
|
Cytoplasm | 1 | 2009 | 1539 | 0.060 |
Why?
|
Regeneration | 1 | 2012 | 1485 | 0.060 |
Why?
|
Rats, Inbred SHR | 2 | 2013 | 195 | 0.050 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily K | 1 | 2023 | 91 | 0.050 |
Why?
|
Cell Proliferation | 3 | 2013 | 10481 | 0.050 |
Why?
|
Genomics | 3 | 2023 | 5720 | 0.050 |
Why?
|
Cell Adhesion | 1 | 2009 | 3144 | 0.050 |
Why?
|
bcl-X Protein | 1 | 2023 | 411 | 0.050 |
Why?
|
Cell Culture Techniques | 1 | 2009 | 1678 | 0.050 |
Why?
|
Genes, Overlapping | 1 | 2021 | 36 | 0.050 |
Why?
|
Cytotoxicity Tests, Immunologic | 1 | 2021 | 329 | 0.050 |
Why?
|
Cyclin-Dependent Kinase 9 | 1 | 2021 | 66 | 0.050 |
Why?
|
Cell Differentiation | 3 | 2013 | 11483 | 0.050 |
Why?
|
Actins | 1 | 2008 | 2121 | 0.040 |
Why?
|
Up-Regulation | 1 | 2009 | 4217 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2008 | 2503 | 0.040 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2023 | 1157 | 0.040 |
Why?
|
Brain Ischemia | 1 | 2012 | 3265 | 0.040 |
Why?
|
Antigen Presentation | 1 | 2023 | 1284 | 0.040 |
Why?
|
Animals | 11 | 2023 | 168757 | 0.040 |
Why?
|
Endothelium, Vascular | 2 | 2008 | 4456 | 0.040 |
Why?
|
Rats | 5 | 2013 | 24260 | 0.040 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2021 | 635 | 0.040 |
Why?
|
Mice, Inbred NOD | 1 | 2021 | 1878 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2023 | 1434 | 0.040 |
Why?
|
Platelet Factor 4 | 1 | 2016 | 129 | 0.040 |
Why?
|
Oncogene Proteins | 1 | 2021 | 749 | 0.040 |
Why?
|
Phosphorylation | 1 | 2008 | 8436 | 0.030 |
Why?
|
Mice | 6 | 2023 | 81183 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-sis | 1 | 2016 | 251 | 0.030 |
Why?
|
Heparitin Sulfate | 1 | 2016 | 225 | 0.030 |
Why?
|
Ligands | 1 | 2023 | 3282 | 0.030 |
Why?
|
Binding, Competitive | 1 | 2016 | 1157 | 0.030 |
Why?
|
Thrombospondin 1 | 1 | 2016 | 250 | 0.030 |
Why?
|
Genome | 1 | 2023 | 1808 | 0.030 |
Why?
|
Myocardial Ischemia | 1 | 2005 | 2148 | 0.030 |
Why?
|
C-Reactive Protein | 1 | 2006 | 3778 | 0.030 |
Why?
|
Glycosaminoglycans | 1 | 2016 | 624 | 0.030 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2021 | 3557 | 0.030 |
Why?
|
Humans | 15 | 2023 | 744343 | 0.030 |
Why?
|
Injections, Intraventricular | 1 | 2013 | 230 | 0.030 |
Why?
|
Apoptosis | 2 | 2023 | 9727 | 0.030 |
Why?
|
Tumor Cells, Cultured | 1 | 2021 | 6314 | 0.030 |
Why?
|
Cell Survival | 2 | 2013 | 5882 | 0.030 |
Why?
|
Bromodeoxyuridine | 1 | 2012 | 322 | 0.030 |
Why?
|
Time Factors | 2 | 2012 | 40075 | 0.020 |
Why?
|
Cattle | 2 | 2008 | 3922 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor A | 2 | 2016 | 3508 | 0.020 |
Why?
|
Analysis of Variance | 2 | 2012 | 6365 | 0.020 |
Why?
|
Atherosclerosis | 1 | 2006 | 3445 | 0.020 |
Why?
|
Stem Cell Niche | 1 | 2013 | 346 | 0.020 |
Why?
|
Disease Models, Animal | 3 | 2013 | 18029 | 0.020 |
Why?
|
Aorta | 2 | 2008 | 2061 | 0.020 |
Why?
|
Cell Count | 1 | 2012 | 1856 | 0.020 |
Why?
|
Genome, Human | 1 | 2021 | 4420 | 0.020 |
Why?
|
Lung Neoplasms | 1 | 2012 | 13102 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2012 | 10943 | 0.020 |
Why?
|
Neuroprotective Agents | 1 | 2013 | 941 | 0.020 |
Why?
|
Nitric Oxide Donors | 1 | 2006 | 121 | 0.020 |
Why?
|
Nitroprusside | 1 | 2006 | 275 | 0.020 |
Why?
|
Platelet Adhesiveness | 1 | 2006 | 161 | 0.020 |
Why?
|
Disulfides | 1 | 2008 | 457 | 0.020 |
Why?
|
Brain | 1 | 2012 | 26385 | 0.020 |
Why?
|
Proteins | 1 | 2021 | 6103 | 0.020 |
Why?
|
Behavior, Animal | 1 | 2013 | 1881 | 0.020 |
Why?
|
Disability Evaluation | 1 | 2012 | 1827 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2016 | 2727 | 0.020 |
Why?
|
Embryonic Stem Cells | 1 | 2012 | 1294 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2012 | 3616 | 0.020 |
Why?
|
Protein Binding | 1 | 2016 | 9386 | 0.020 |
Why?
|
Cell Movement | 2 | 2008 | 5217 | 0.020 |
Why?
|
Tubulin | 1 | 2008 | 695 | 0.010 |
Why?
|
Rats, Inbred Strains | 1 | 2005 | 2186 | 0.010 |
Why?
|
P-Selectin | 1 | 2006 | 600 | 0.010 |
Why?
|
Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2006 | 641 | 0.010 |
Why?
|
Platelet-Derived Growth Factor | 1 | 2005 | 625 | 0.010 |
Why?
|
Cytoskeleton | 1 | 2008 | 1185 | 0.010 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2006 | 1155 | 0.010 |
Why?
|
Capillaries | 1 | 2005 | 773 | 0.010 |
Why?
|
Recovery of Function | 1 | 2012 | 2925 | 0.010 |
Why?
|
Microtubules | 1 | 2008 | 1090 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2021 | 12261 | 0.010 |
Why?
|
Signal Transduction | 2 | 2016 | 23403 | 0.010 |
Why?
|
Cells, Cultured | 2 | 2008 | 19229 | 0.010 |
Why?
|
Down-Regulation | 1 | 2008 | 3002 | 0.010 |
Why?
|
Male | 4 | 2013 | 350118 | 0.010 |
Why?
|
Nanostructures | 1 | 2005 | 551 | 0.010 |
Why?
|
Models, Biological | 1 | 2016 | 9583 | 0.010 |
Why?
|
Nerve Tissue Proteins | 1 | 2012 | 4462 | 0.010 |
Why?
|
Microscopy, Fluorescence | 1 | 2006 | 2699 | 0.010 |
Why?
|
Models, Animal | 1 | 2005 | 2171 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2006 | 6622 | 0.010 |
Why?
|
Peptides | 1 | 2006 | 4409 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2006 | 9734 | 0.010 |
Why?
|
Female | 3 | 2021 | 380194 | 0.010 |
Why?
|
Cytokines | 1 | 2005 | 7322 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 2006 | 9274 | 0.010 |
Why?
|
Concepts
(134)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(27)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_